High-capacity redox control at the plasma membrane of mammalian cells: Trans-membrane, cell surface, and serum NADH-oxidases

Antioxidants and Redox Signaling

Volumn 2, Issue 2, 2000, Pages 231-242

  Berridge, Michael V ^a   Tan, An S ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TETRAZOLIUM;

ANIMAL CELL; CANCER DIAGNOSIS; CELL MEMBRANE; CELL MEMBRANE TRANSPORT; CELL SURFACE; ELECTRON TRANSPORT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MAMMAL CELL; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TUMOR VOLUME;

ANIMALIA; MAMMALIA;

EID: 0033923221     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2000.2.2-231     Document Type: Review

References (39)

1. AHMED, N., and BERRIDGE, M.V. (1997). Regulation of glucose transport by interleukin-3 in growth factor-dependent and oncogene-transformed bone marrow-derived cell lines. Leukemia Res., 21, 609-618.
2. AHMED, N., and BERRIDGE, M.V. (1998). Transforming oncogenes regulate glucose transport by increasing transporter affinity for glucose: contrasting effects of oncogenes and heat stress in a murine marrow-derived cell line. Life Sci., 63, 1887-1903.
3. ASARD, H., BERCZI, A., and CAUBERGS, R.J. (eds.) (1998). Plasma Membrane Redox Systems and Their Role in Biological Stress and Disease. (Kluwer, Dordrecht).
4. BERRIDGE, M.V., and TAN, A.S. (1993). Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 303, 474-482.
5. BERRIDGE, M.V., and TAN, A.S. (1995). Interleukin-3 facilitates glucose transport in a myeloid cell line by regulating the affinity of the glucose transporter for glucose: involvement of protein phosphorylation in transporter activation. Biochem. J. 305, 843-851.
6. BERRIDGE, M.V., and TAN, A.S. (1998). Trans-plasma membrane electron transport: a cellular assay for NADH-and NADPH-oxidase based on extracellular, superoxide-mediated reduction of the sulfonated tetrazolium salt WST-1. Protoplasma 205, 74-82.
7. BERRIDGE, M.V., and TAN, A.S. (1999). Diagnosis and monitoring of cancer. Provisional Patent, NZ334232.
8. BERRIDGE, M.V., and TAN, A.S. (2000). Cell surface NAD(P)H-oxidase: relationship to trans-plasma membrane NADH-oxidoreductase and a potential source of circulating NADH-oxidase. Antiox. Redox Signal. 2,. 277-288.
9. BERRIDGE, M.V., TAN, A.S., McCOY, K.D., and WANG, R. (1996). The biochemical and cellular basis of cell proliferation assays that use tetrazolium salts. Biochemica 4,15-20.
10. BRIGHTMAN, A.O., WANG, J., MIU, R.K., SUN, I.L., BARR, R., CRANE, F.L., and MORRÉ, D.J. (1992). A growth factor-and hormone-stimulated NADH oxidase from rat liver plasma membrane. Biochim. Biophys. Acta 1105, 109-117.
11. CHUEH, P.J., MORRÉ, D.J., WILKINSON, F.E., GIBSON, J., and MORRÉ, D.M. (1997). A 33.5-kDa heat-and protease-resistant NADH oxidase inhibited by capsaicin from sera of cancer patients. Archiv. Biochem. Biophys. 342, 38-47.
12. CRANE, F.L., SUN, I.L., CLARK, M.G., GREBING, C., and LOW, H. (1985). Transplasma-membrane redox systems in growth and development. Biochim. Biophys. Acta, 811, 233-264.
13. DEL CASTILLO-OLIVARES, A., YANTIRI, F., CHUEH, P.-J., WANG, S., SWEETING, M., SEDLAK, D., MORRÉ, D.M., BURGESS, J., and MORRÉ, D.J. (1998). A drug-responsive and protease-resistant peripheral NADH oxidase complex from the surface of HeLa S cells. Archiv. Biochem. Biophys. 358, 125-140.
14. GOODWIN, C.J., HOLT, S.J., RILEY, P.A., DOWNES, S., and MARSHALL, N.J. (1996). Growth hormone-responsive DT-diaphorase-mediated bioreduction of tetrazolium salts. Biochem. Biophys. Res. Commun. 226, 935-941.
15. HAMILTON, J.A., VAIRO, G., and LINGELBACH, S.R. (1988). Activation and proliferation signals in murine macrophages: stimulation of glucose uptake by hemopoietic growth factors and other agents. J. Cell. Physiol. 134, 405-412.
16. ISHIYAMA, M., SHIGA, M., SASAMOTO, K., MIZOGUCHI, M., and HE, P.G. (1993). A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye. Chem. Pharmaceut. Bull. 41, 1118-1122.
17. ISHIYAMA, M., SASAMOTO, K., SHIGA, M., OHKURA, Y., UENO, K., NISHIYAMA, K., and TANIGUCHI, I. (1995). Novel disulfonated tetrazolium salt that can be reduced to a water-soluble formazan and its application to the assay of lactate-dehydrogenase. Analyst 120, 113-116.
18. KISHI, T., MORRÉ, D.M., and MORRÉ, D.J. (1999). The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity. Biochim. Biophys. Acta 1412, 66-77.
19. LARM, J.A., VAILLANT, F., LINNANE, A.W., and LAWEN, A. (1994). Up-regulation of the plasma membrane oxidoreductase as a prerequisite for the viability of human Namalwa rho 0 cells. J. Biol. Chem. 269, 30097-30100.
20. McCOY, K.D., AHMED, N., TAN, A.S., and BERRIDGE, M.V. (1997). The hemopoietic growth factor, interleukin-3, promotes glucose transport by increasing the specific activity and maintaining the affinity for glucose of plasma membrane glucose transporters. J. Biol. Chem. 272, 17276-17282.
21. MERRALL, N.W., PLEVIN, R., and GOULD, G.W. (1993). Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell. Signal., 5, 667-675.
22. + antiport. Cytoplasmic alkalinization is not required for lymphocyte proliferation. J. Biol. Chem. 260, 12500-12507.
23. MORRÉ, D.J., and BRIGHTMAN, A.O. (1991). NADH oxidase of plasma membranes. J. Bioenerg. Biomem. 23, 469-189.
24. MORRÉ, D.J., CHUEH, P.J., and MORRÉ, D.M. (1995a). Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc. Natl. Acad. Sci. USA, 92, 1831-1835.
25. MORRÉ, D.J., WILKINSON, F.E., LAWRENCE, J., CHO, N.M., and PAULIK, M. (1995b). Identification of antitumor sulfonylurea binding-proteins of Hela plasma-membranes. Biochim. Biophys. Acta-Biomembranes 1236,237-243.
26. MORRÉ, D. J., SUN, E., GEILEN, C., WU, L.Y., DE CABO, R., KRASAGAKIS, K., ORFANOS, C.E., and MORRÉ, D.M. (1996a). Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines. Eur. J. Cancer 32A, 1995-2003.
27. MORRÉ, D.J., WILKINSON, F.E., KIM, C., CHO, N., LAWRENCE, J., MORRÉ, D.M., and McCLURE, D. (1996b). Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media. Biochim. Biophys. Acta, 1280, 197-206.
28. MORRÉ, D.J., CALDWELL, S., MAYORGA, A., WU, L.Y., and MORRÉ, D.M. (1997). NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients. Archiv. Biochem. Biophys. 342, 224-230.
29. MOSMANN, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Meth. 65, 55-63.
30. O'DONNELL, V.B., and AZZI, A. (1996). High rates of extracellular superoxide generation by cultured human fibroblasts: involvement of a lipid-metabolizing enzyme. Biochem. J. 318, 805-812.
31. SCHRENZEL, J., SERRANDER, L., BANFI, B., NUSSE, O., FOUYOUZI, R., LEW, D.P., DEMAUREX, N., and KRAUSE, K.H. (1998). Electron currents generated by the human phagocyte NADPH oxidase. Nature 392, 734-737.
32. SHIMOMURA, Y., KAWADA, T., and SUZUKI, M. (1989). Capsaicin and its analogs inhibit the activity of NADH-coenzyme Q oxidoreductase of the mitochondrial respiratory chain. Arch. Biochem. Biophys. 270, 573-577.
33. TAN, A.S., and BERRIDGE, M.V. (2000). Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. J. Immunol. Methods 238, 59-68.
34. + exchange involvement in colony-stimulating factor-1-stimulated macrophage proliferation. Evidence for a requirement during late G1 of the cell cycle but not for early growth factor responses. J. Biol. Chem. 265, 16929-16939.
35. VILLALBA, J.M., NAVARRO, F., CORDOBA, F., SERRANO, A., ARROYO, A., CRANE, F.L., and NAVAS, P. (1995). Coenzyme Q reductase from liver plasma membrane: purification and role in trans-plasma-membrane electron transport. Proc. Natl. Acad. Sci. USA, 92, 4887-4891.
36. VOEGTLIN, C., JOHNSON, J.M., and DYER, H.A. (1925). Quantitative estimation of the reducing power of normal and cancer tissue. J. Pharmacol. Exp. Ther. 24, 305.
37. WADA, H.G., INDELICATO, S.R., MEYER, L., KITAMURA, T., MIYAJIMA, A., KIRK, G., MUIR, V.C., and PARCE, J.W. (1993). GM-CSF triggers a rapid, glucose dependent extracellular acidification by TF-1 cells-evidence for sodium/proton antiporter and PKC mediated activation of acid production. J. Cell Physiol. 154, 129-138.
38. YAMAGATA, M., and TANNOCK, I.F. (1996). The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects. Br. J. Cancer 73, 1328-1334.
39. ZURBRIGGEN, R., and DREYER, J.L. (1996). The plasma membrane NADH-diaphorase is active during selective phases of the cell cycle in mouse neuroblastoma cell line NB41A3. Its relation to cell growth and differentiation. Biochim. Biophys. Acta 1312, 215-222.